ECO Animal Health Group plc (LON:EAH – Get Free Report) hit a new 52-week low during trading on Tuesday . The company traded as low as GBX 83 ($1.05) and last traded at GBX 83 ($1.05), with a volume of 42859 shares changing hands. The stock had previously closed at GBX 86.80 ($1.10).
Wall Street Analyst Weigh In
Separately, Shore Capital reissued a “buy” rating on shares of ECO Animal Health Group in a report on Thursday, February 22nd.
Get Our Latest Stock Analysis on EAH
ECO Animal Health Group Stock Performance
About ECO Animal Health Group
ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, mange, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.
See Also
- Five stocks we like better than ECO Animal Health Group
- 3 Small Caps With Big Return Potential
- 3 Value Stocks Too Small For Buffett’s Portfolio
- How to Calculate Options Profits
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- ETF Screener: Uses and Step-by-Step Guide
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for ECO Animal Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ECO Animal Health Group and related companies with MarketBeat.com's FREE daily email newsletter.